ArticleJournal of pharmaceutical analysis2017
Isolation, characterization and chromatography based purification of antibacterial compound isolated from rare endophytic actinomycetes
Article in Journal of pharmaceutical analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Multiplexing antibiotic screening assay in droplet microfluidics.Scientific reports · 2026Article
- Antimicrobial potential and extracellular metabolite profiling of bichitrapur mangrove sediment derived Micromonospora sp. BSS-D-04 and Streptomyces sp. BSS-D-05 using LC-MS/MS and GC-MS analysis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Metagenomic nanopore sequencing for exploring the nature of antimicrobial metabolites of Bacillus haynesii.AMB Express · 2024Article
- Biogenic synthesis of silver nanoparticle byFrontiers in microbiology · 2024Article
- Isolation and identification of endophytic actinobacteria fromFood science & nutrition · 2023Article
- Micrococcus spp. as a promising source for drug discovery: A review.Journal of industrial microbiology & biotechnology · 2023Review
- Structural elucidation of a compound extracted fromBioinformation · 2023Article
- Macrolactin A mediated biocontrol ofFrontiers in microbiology · 2023Article
- Bioactive potentiality of secondary metabolites from endophytic bacteria against SARS-COV-2: An in-silico approach.PloS one · 2022Article
- Exploring the Nature of the Antimicrobial Metabolites Produced byAntibiotics (Basel, Switzerland) · 2021Article
- A Metagenomic Nanopore Sequence Analysis Combined with Conventional Screening and Spectroscopic Methods for Deciphering the Antimicrobial Metabolites Produced byAntibiotics (Basel, Switzerland) · 2021Article
- Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin XScientific reports · 2021Article
- Integrated Genomic and Functional Characterization of the Anti-diabetic Potential of Arthrobacter sp. SW1.Current microbiology · 2021Article
- Eco-friendly synthesis of silver nanoparticles bySaudi journal of biological sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endophytic actinomycetes are considered as one of the relatively unexplored potential sources in search of antibiotic producer against antibiotic resistant pathogens. A potent strain isolated from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.